Daniel Timothy Hudson
CIK: 0002123678
Daniel Timothy Hudson's purchase track record
Daniel Timothy Hudson has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 7/9/2026 | HNRG | $83K | -12.3% | pending | — |
| 6/24/2026 | HNRG | $256K | -18.0% | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| HNRG | ▲ Buy | Open Market | 2,500 | $42K | 7/9/2026 | View on chart |
| HNRG | ▲ Buy | Open Market | 2,500 | $41K | 7/9/2026 | View on chart |
| HNRG | ▲ Buy | Open Market | 5,000 | $85K | 6/29/2026 | View on chart |
| HNRG | ▲ Buy | Open Market | 5,000 | $85K | 6/29/2026 | View on chart |
| HNRG | ▲ Buy | Open Market | 2,000 | $35K | 6/25/2026 | View on chart |
| HNRG | ▲ Buy | Open Market | 3,000 | $51K | 6/24/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Hallador Energy Completes $600M Loan for Power Plant
Hallador Energy has closed a $600 million loan, a key step in financing its new power plant project. This move addresses the company's capital needs for expansion, though the market is watching how effectively these funds will be deployed. The stock currently trades below its average analyst target, reflecting ongoing scrutiny of its valuation and execution capabilities.
Hallador Energy Completes $600M Loan for Power Plant. Hallador Energy has closed a $600 million loan, a key step in financing its new power plant project. This move addresses the company's capital needs for expansion, though the market is watching how effectively these funds will be deployed. The stock currently trades below its average analyst target, reflecting ongoing scrutiny of its valuation and execution capabilities.